scholarly article | Q13442814 |
P356 | DOI | 10.1006/BBRC.1999.1640 |
P698 | PubMed publication ID | 10548501 |
P2093 | author name string | Kikuchi K | |
Mori M | |||
Kurihara M | |||
Fujino M | |||
Nishimura O | |||
Abe M | |||
Shimomura Y | |||
Kurokawa T | |||
Sugo T | |||
Onda H | |||
Kitada C | |||
Shintani Y | |||
P2860 | cites work | Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1 | Q22010429 |
Molecular characterization of the melanin-concentrating-hormone receptor | Q22010430 | ||
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 | Q22010575 | ||
Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor | Q24311708 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | G protein-coupled receptor | Q38173 |
P304 | page(s) | 123-129 | |
P577 | publication date | 1999-11-01 | |
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). | |
P478 | volume | 265 |
Q53165879 | An investigation into the origin of the biased agonism associated with the urotensin II receptor activation. |
Q42667921 | Behavioral effects of urotensin-II centrally administered in mice |
Q28260943 | Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes |
Q35043105 | Cardiostimulant effects of urotensin-II in human heart in vitro |
Q36597958 | Cellular and molecular biology of orphan G protein-coupled receptors |
Q54708765 | Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat. |
Q35191049 | Comparative distribution and in vitro activities of the urotensin II-related peptides URP1 and URP2 in zebrafish: evidence for their colocalization in spinal cerebrospinal fluid-contacting neurons |
Q34479147 | Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families |
Q43868528 | Concordant localization of functional urotensin II and urotensin II-related peptide binding sites in the rat brain: Atypical occurrence close to the fourth ventricle. |
Q43264408 | Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat. |
Q43264253 | Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats |
Q58855829 | Design, Synthesis, Conformational Analysis, and Biological Studies of Urotensin-II Lactam Analogues |
Q42059806 | Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey |
Q28188986 | Discovery and mapping of ten novel G protein-coupled receptor genes |
Q34260110 | Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticity |
Q73307200 | Effect of human urotensin-II infusion on hemodynamics and cardiac function |
Q35105373 | Functional Assays for Identifying Ligands at Orphan G Protein-Coupled Receptors |
Q93551696 | G Protein-Coupled Receptors |
Q43229377 | Human urotensin II in internal mammary and radial arteries of patients undergoing coronary surgery. |
Q28140469 | Human urotensin II mediates vasoconstriction via an increase in inositol phosphates |
Q34204725 | Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease |
Q35047377 | Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines |
Q98629482 | Identification and signaling characterization of four urotensin II receptor subtypes in the western clawed frog, Xenopus tropicalis |
Q28199576 | Identification of four novel human G protein-coupled receptors expressed in the brain |
Q28215417 | Identification of neuropeptide W as the endogenous ligand for orphan G-protein-coupled receptors GPR7 and GPR8 |
Q28208515 | Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain |
Q24672927 | Is urotensin-II the new endothelin? |
Q48675996 | Localization of the urotensin II receptor in the rat central nervous system |
Q40735770 | Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey |
Q44114224 | New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide |
Q34837608 | Novel G-protein-coupled receptor genes expressed in the brain: continued discovery of important therapeutic targets |
Q28202637 | Novel human G-protein-coupled receptors |
Q34442018 | Orphan G protein-coupled receptors in the CNS. |
Q34175467 | Orphan G-protein-coupled receptors and natural ligand discovery |
Q24674639 | Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1 |
Q41981084 | Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain. |
Q35873683 | Postgenomic characterization of G-protein-coupled receptors |
Q31833949 | Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries |
Q34001118 | Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis |
Q39084425 | RGS2 regulates urotensin II-induced intracellular Ca2+ elevation and contraction in glomerular mesangial cells. |
Q35650633 | Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis. |
Q36902874 | Role of urotensin II and its receptor in health and disease |
Q28182651 | Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects |
Q87245995 | Sequence-structure based phylogeny of GPCR Class A Rhodopsin receptors |
Q48372089 | Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma. |
Q30658328 | Singular contributions of fish neuroendocrinology to mammalian regulatory peptide research |
Q34278176 | Somatostatins and their receptors in fish |
Q73568813 | Specific expression of the urotensin II gene in sacral motoneurons of developing rat spinal cord |
Q38533390 | State-dependent calcium mobilization by urotensin-II in cultured human endothelial cells |
Q30486707 | The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors |
Q33599835 | The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features |
Q28241656 | The expression of urotensin II receptor (U2R) is up-regulated by interferon-gamma |
Q24675590 | The role of urotensin II in cardiovascular and renal physiology and diseases |
Q28211211 | The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat |
Q34981350 | The use of constitutively active GPCRs in drug discovery and functional genomics |
Q42213734 | The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals |
Q36760529 | Therapeutic potential of blockade of the urotensin II system in systemic hypertension |
Q73746130 | UROTENSIN II: BETTER THAN SOMATOSTATIN FOR PORTAL HYPERTENSION? |
Q41767436 | Update on the urotensinergic system: new trends in receptor localization, activation, and drug design |
Q54414485 | Urantide conformation and interaction with the urotensin-II receptor. |
Q44654245 | Urotensin II causes fatal circulatory collapse in anesthesized monkeys in vivo: a “vasoconstrictor” with a unique hemodynamic profile |
Q36384743 | Urotensin II in invertebrates: from structure to function in Aplysia californica |
Q48627768 | Urotensin II inhibits carotid sinus baroreflex in anesthetized male rats |
Q44463826 | Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney |
Q28584202 | Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons |
Q50796108 | Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes. |
Q48877778 | Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. |
Q74531840 | Urotensin II: a new mediator in cardiopulmonary regulation? |
Q40166897 | Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension |
Q28250440 | Urotensin II: ancient hormone with new functions in vertebrate body fluid regulation |
Q33846563 | Urotensin II: fish neuropeptide catches orphan receptor |
Q37148984 | Urotensin II: lessons from comparative studies for general endocrinology. |
Q93498779 | Urotensin-II |
Q35779239 | Urotensin-II and the cardiovascular system--the importance of developing modulators |
Q64940598 | Urotensin-II gene rs228648 polymorphism associated with the risk of diabetes mellitus. |
Q39039151 | Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. |
Q35867016 | Urotensin-II-Mediated Reactive Oxygen Species Generation via NADPH Oxidase Pathway Contributes to Hepatic Oval Cell Proliferation |